Page last updated: 2024-10-26

dipyridamole and Prosthesis Durability

dipyridamole has been researched along with Prosthesis Durability in 2 studies

Dipyridamole: A phosphodiesterase inhibitor that blocks uptake and metabolism of adenosine by erythrocytes and vascular endothelial cells. Dipyridamole also potentiates the antiaggregating action of prostacyclin. (From AMA Drug Evaluations Annual, 1994, p752)
dipyridamole : A pyrimidopyrimidine that is 2,2',2'',2'''-(pyrimido[5,4-d]pyrimidine-2,6-diyldinitrilo)tetraethanol substituted by piperidin-1-yl groups at positions 4 and 8 respectively. A vasodilator agent, it inhibits the formation of blood clots.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Nagata, M1
Ishii, K1
Yano, Y1
Hara, M1
Sugio, K1
Tanigawa, M1
Nakamura, K1
Yonezawa, T1
Kuwabara, M1
Onizuka, T1
Clyne, CA1
Archer, TJ1
Atuhaire, LK1
Chant, AD1
Webster, JH1

Trials

1 trial available for dipyridamole and Prosthesis Durability

ArticleYear
Random control trial of a short course of aspirin and dipyridamole (Persantin) for femorodistal grafts.
    The British journal of surgery, 1987, Volume: 74, Issue:4

    Topics: Aspirin; Clinical Trials as Topic; Dipyridamole; Drug Therapy, Combination; Female; Humans; Male; Po

1987

Other Studies

1 other study available for dipyridamole and Prosthesis Durability

ArticleYear
[Experience with atrioventricular valve replacement in infants and children].
    Kyobu geka. The Japanese journal of thoracic surgery, 1994, Volume: 47, Issue:3

    Topics: Adolescent; Child; Child, Preschool; Dipyridamole; Female; Follow-Up Studies; Heart Valve Prosthesis

1994